Astrazeneca Plc (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,832,000 | 8,072,000 | 5,673,000 | 3,413,000 | 5,369,000 |
| Marketable Securities | 302,000 | 411,000 | 442,000 | 813,000 | 885,000 |
| Receivables | 7,386,000 | 6,000,000 | 5,237,000 | 5,342,000 | 6,046,000 |
| Inventories | 4,024,000 | 3,683,000 | 3,562,000 | 3,123,000 | 3,193,000 |
| Other current assets | 0 | 0 | 16,000 | 131,000 | 70,000 |
| TOTAL | $19,544,000 | $18,166,000 | $14,930,000 | $12,822,000 | $15,563,000 |
| Non-Current Assets | |||||
| PPE Net | 8,251,000 | 7,707,000 | 7,475,000 | 7,347,000 | 7,688,000 |
| Investments And Advances | 1,318,000 | 1,334,000 | 1,618,000 | 1,624,000 | 1,520,000 |
| Intangibles | 32,792,000 | 32,324,000 | 31,373,000 | 31,287,000 | 32,501,000 |
| Other Non-Current Assets | 4,824,000 | 4,581,000 | 4,533,000 | 4,131,000 | 4,105,000 |
| TOTAL | $47,185,000 | $45,946,000 | $44,999,000 | $44,389,000 | $45,814,000 |
| Total Assets | $66,729,000 | $64,112,000 | $59,929,000 | $57,211,000 | $61,377,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,194,000 | 3,402,000 | 3,958,000 | 2,289,000 | 1,822,000 |
| Accounts payable and accrued liabilities | 15,785,000 | 13,406,000 | 12,028,000 | 12,633,000 | 13,987,000 |
| Other current liabilities | 1,009,000 | 630,000 | 647,000 | 680,000 | 759,000 |
| TOTAL | $20,307,000 | $18,942,000 | $18,183,000 | $17,043,000 | $18,117,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 17,505,000 | 18,271,000 | 15,150,000 | 15,634,000 | 15,730,000 |
| Other Non-Current Liabilities | 10,368,000 | 10,702,000 | 10,430,000 | 9,847,000 | 10,480,000 |
| TOTAL | $30,784,000 | $31,552,000 | $28,088,000 | $27,952,000 | $28,664,000 |
| Total Liabilities | $51,091,000 | $50,494,000 | $46,271,000 | $44,995,000 | $46,781,000 |
| Shareholders' Equity | |||||
| Common Shares | 328,000 | 328,000 | 328,000 | 328,000 | 328,000 |
| Retained earnings | 5,299,000 | 1,876,000 | 1,913,000 | 448,000 | 2,812,000 |
| Other shareholders' equity | 2,040,000 | 3,462,000 | 3,467,000 | 3,494,000 | 3,515,000 |
| TOTAL | $15,638,000 | $13,618,000 | $13,658,000 | $12,216,000 | $14,596,000 |
| Total Liabilities And Equity | $66,729,000 | $64,112,000 | $59,929,000 | $57,211,000 | $61,377,000 |